What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?

Markus Gosch; Hermann Josef Bail; Sebastian Grueninger; Ulla Stumpf; Christian Kammerlander; Susanne Wicklein

doi:10.1007/s11657-020-0690-2

What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?

Markus Gosch^* (First author)
, Hermann Josef Bail (Co-author)
, Sebastian Grueninger (Co-author)
, Ulla Stumpf
, Christian Kammerlander
, Susanne Wicklein (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	20
Journal	ARCHIVES OF OSTEOPOROSIS
Volume	15
Issue number	1
DOIs	https://doi.org/10.1007/s11657-020-0690-2
Publication status	Published - 2020

Keywords

CARE
EPIDEMIOLOGY
DIAGNOSIS
MORTALITY
BONE

Access to Document

10.1007/s11657-020-0690-2

Cite this

@article{110fea320c2f48d183080cdaa0b53f71,

title = "What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?",

keywords = "CARE, EPIDEMIOLOGY, DIAGNOSIS, MORTALITY, BONE",

author = "Markus Gosch and Bail, \{Hermann Josef\} and Sebastian Grueninger and Ulla Stumpf and Christian Kammerlander and Susanne Wicklein",

note = "all:Paracelsus Medical University Nuremberg, Nuremberg, Germany; ",

year = "2020",

doi = "10.1007/s11657-020-0690-2",

language = "English",

volume = "15",

pages = "20",

journal = "ARCHIVES OF OSTEOPOROSIS",